Teate vaade
Ettevõte AS PRFoods
Tüüp Korraldatud teave
Kategooria Juhtkonna vaheteadaanne või kvartaalne finantsaruanne
Avaldamise aeg 30 nov 2019 18:40:00 +0200
Manused
PRFoods-10002966111-en.pdf
PRFoods-10002966113-et.pdf
Keeleversioonid
Keel English
Valuuta
Pealkiri PRF: Consolidated Unaudited Interim Report of AS PRFoods for the 1st quarter and 3 months of 2019/2020 financial year
Tekst
OVERVIEW OF ECONOMIC ACTIVITIES

PRFoods' sales of 1st quarter 2019/2020 financial year was 19.3 million euros.
Net profit 0.57 million euros, four times higher than Q3/2018. EBITDA 1.47
million euros, growth 31%.

MANAGEMENT COMMENTARY

We  are happy to announce that based on  the first quarter of the financial year
(3rd  quarter of  2019) the restructuring  processes commenced  within the Group
during the last financial year, are demonstrating positive results.

The reporting period was characterized by a general decline in the prices of raw
materials  of fishery products, resulting in a  fall in the prices of fish, fish
fillets  and smoked products. In spite of the approximately 5% price drop of the
Group's  main products, we were able to  keep the total sales practically at the
level  of the last year. The third quarter sales for 2019 totalled 19.33 million
euros (Q3 2018: 19.39 million euros).

The Group's consolidated EBITDA for the reporting period was 1.47 million euros,
an  increase of  31% compared to  the same  period last  year, which  was mainly
affected  by  the  gain  from  revaluation  of biological assets by 0.85 million
euros. Operating EBITDA (i.e. excluding one-offs and fish stock revaluation) was
0.73 million  euros (Q3 2018:  1.06 million euros).  Net profit was 0.57 million
euros,  almost four times  higher than the  net profit for  the same period last
year (Q3 2018: 0.14 million euros).

The  Group's manufacturing and sales companies (Heimon Kala, John Ross Jr., Coln
Valley  Smokery, Trio Trading, Vettel)  significantly improved their operational
results compared to the same quarter last year; incl. exceeding the planned ones
by  ca 0.3 million euros in  total. The decline in  operating EBITDA compared to
the previous year was attributable to the weaker performance of the Swedish fish
farming  unit (Överumans Fisk) due  to the decline in  the market price of fish,
the  recovery of which from its lowest level  in the last three years is already
noticeable.

We  are optimistic about getting additional farming licences already in 2020. We
will  continue to make  necessary preparations to  increase the farming capacity
which  in  turn  would  increase  the  quality  raw material supply from our own
Estonian fish farms.

PRFoods'  focus has been on improving cash flow from operating activities, which
is  reflected in  Q3 2019 positive  cash flow  from operating  activities in the
amount  of 1.3 million  euros compared  to 0.1 million  euros in the same period
last  year.  The  Company's  net  debt  was 19.9 million euros as at 30.09.2019
(30.09.2018:  21.9 million euros), which will decrease at the end of the year by
repayments  of investment loans and higher  cash balance due to Christmas sales.
As  at 30.09.2019, the Group's working capital was negative by 3.0 million euros
as  current liabilities include liabilities to  related parties in the amount of
4.1 million  euros, which  by their  nature are  long-term but due to accounting
principles shall be reported as current.

We  will continue to merge  the business operations of  the Estonian and Finnish
companies  and to create synergies, especially  in product development and sales
both  in the domestic and export markets. The merger of the Finnish subsidiaries
into  one company is proceeding according to plan and Trio Trading Oy and Heimon
Kala  Oy will  be merged  into one  company, which  will continue under the name
Heimon  Kala Oy. In  Estonia we have  launched a Finnish-Estonian  joint brand -
Heimon  Kala and for the first time  in history we have successfully entered the
local retail market with trout farmed in Saaremaa, Estonia.

Regarding  the outbreak of  listeria that hit  the Estonian fishing industry, we
can   confirm  that  PRFoods  companies  have  passed  all  additional  controls
successfully.  The biggest role here is played  by our internal quality and food
safety  controls in our companies, including  the day-to-day controls in our own
laboratories  from the purchase of raw fish  to the dispatch of the product from
the factory.

The  launch of John Ross  Jr.'s renewed brand started  at the end of the quarter
and we expect significant growth in the UK market in the coming quarters.

In  order to achieve  our goals in  the coming periods,  the Group has engaged a
strengthened  management team of professionals.  PRFoods team has done excellent
job  in  developing  our  business  and  profitability.  PRFoods' balance sheet,
production  and customer  base are  strong, and  we look  optimistically towards
future.

Big  changes are  always challenging  for people  in the  company and  I am very
thankful that our team has enthusiastically embraced the changes and given their
best.

KEY RATIOS

INCOME STATEMENT

+----------------------+-------+-------+-------+-------+-------+-------+-------+
|mln EUR               |3Q 2019|2Q 2019|1Q 2019|4Q 2018|3Q 2018|2Q 2018|1Q 2018|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|Sales                 |   19,3|   21.5|   18.1|   26.7|   19.4|   22.1|   22.7|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|Gross profit          |    2,6|    2.1|    2.1|    4.7|    3.0|    1.8|    2.4|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|EBITDA from operations|    0,7|    0.3|    0.2|    2.4|    1.1|   -0.2|    0.7|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|EBITDA                |    1,5|    0.3|   -0.5|    0.8|    1.1|    0.3|    0.6|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|EBIT                  |    1,0|   -0.3|   -1.0|    0.2|    0.6|   -0.2|    0.1|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|EBT                   |    0,8|   -0.4|   -1.2|    0.0|    0.4|   -0.5|   -0.2|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|Net profit (-loss)    |    0,6|   -0.6|   -1.2|    0.2|    0.1|   -1.1|   -0.2|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|Gross margin          |  13,4%|   9.8%|  11.7%|  17.7%|  15.2%|   7.9%|  10.6%|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|Operational EBITDA    |       |       |       |       |       |       |       |
|margin                |   3,8%|   1.4%|   1.1%|   9.1%|   5.4%|  -1.1%|   3.1%|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|EBITDA margin         |   7,6%|   1.4%|  -2.5%|   2.9%|   5.8%|   1.2%|   2.5%|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|EBIT margin           |   5,0%|  -1.2%|  -5.6%|   0.9%|   3.0%|  -1.1%|   0.2%|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|EBT margin            |   3,9%|  -2.0%|  -6.5%|   0.1%|   1.8%|  -2.3%|  -0.9%|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|Net margin            |   2,9%|  -3.0%|  -6.6%|   0.8%|   0.7%|  -5.1%|  -1.0%|
+----------------------+-------+-------+-------+-------+-------+-------+-------+
|Operating expense     |       |       |       |       |       |       |       |
|ratio                 |  13,4%|  11.7%|  14.1%|  11.2%|  13.5%|  12.0%|  10.5%|
+----------------------+-------+-------+-------+-------+-------+-------+-------+

BALANCE SHEET

+---------+----------+----------+----------+----------+----------+----------+----------+
|mln EUR  |30.09.2019|30.06.2019|31.03.2019|31.12.2018|30.09.2018|30.06.2018|31.03.2018|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Net debt |      19,9|      20.5|      18.7|      20.0|      21.9|      18.1|      16.7|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Equity   |      22,8|      21.9|      23.3|      24.2|      24.1|      23.3|      24.3|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Working  |          |          |          |          |          |          |          |
|capital  |      -3,0|      -3.1|      -1.6|       1.0|       2.0|       2.8|       4.6|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Assets   |      62,4|      62.5|      63.5|      65.5|      64.5|      65.5|      66.4|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Liquidity|          |          |          |          |          |          |          |
|ratio    |      0,9x|      0.9x|      0.9x|      1.0x|      1.1x|      1.1x|      1.2x|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Equity   |          |          |          |          |          |          |          |
|ratio    |     36,5%|     35.0%|     36.7%|     37.0%|     37.4%|     35.6%|     36.6%|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Gearing  |          |          |          |          |          |          |          |
|ratio    |     46,6%|     48.3%|     44.5%|     45.2%|     47.6%|     43.7%|     40.7%|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Debt to  |          |          |          |          |          |          |          |
|total    |          |          |          |          |          |          |          |
|assets   |      0,6x|      0.7x|      0.6x|      0.6x|      0.6x|      0.6x|      0.6x|
+---------+----------+----------+----------+----------+----------+----------+----------+
|Net debt |          |          |          |          |          |          |          |
|to EBITDA|      5,4x|      5.1x|      5.4x|      5.1x|      3.8x|      3.1x|      2.6x|
+---------+----------+----------+----------+----------+----------+----------+----------+
|ROE      |     -4,5%|     -6.5%|     -8.2%|     -4.0%|      0.1%|      0.2%|      8.6%|
+---------+----------+----------+----------+----------+----------+----------+----------+
|ROA      |     -1,6%|     -2.3%|     -3.0%|     -1.5%|      0.0%|      0.1%|      4.1%|
+---------+----------+----------+----------+----------+----------+----------+----------+

Consolidated Statement of Financial Position

+---------------------------------+------------+------------+------------+
| Thousand euros                  | 30.09.2019 | 30.09.2018 | 30.06.2019 |
+---------------------------------+------------+------------+------------+
| ASSETS                          |            |            |            |
+---------------------------------+------------+------------+------------+
| Cash and cash equivalents       |      2 327 |      2 788 |      2 583 |
+---------------------------------+------------+------------+------------+
| Receivables and prepayments     |      3 941 |      4 219 |      5 300 |
+---------------------------------+------------+------------+------------+
| Inventories                     |     11 035 |     11 782 |     11 980 |
+---------------------------------+------------+------------+------------+
| Biological assets               |      7 047 |      7 825 |      4 924 |
+---------------------------------+------------+------------+------------+
| Total current assets            |     24 350 |     26 614 |     24 787 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| Deferred income tax             |         58 |         26 |         41 |
+---------------------------------+------------+------------+------------+
| Long-term financial investments |        202 |        134 |        202 |
+---------------------------------+------------+------------+------------+
| Tangible fixed assets           |     14 536 |     14 528 |     14 535 |
+---------------------------------+------------+------------+------------+
| Intangible assets               |     23 261 |     23 195 |     22 969 |
+---------------------------------+------------+------------+------------+
| Total non-current assets        |     38 057 |     37 883 |     37 747 |
+---------------------------------+------------+------------+------------+
| TOTAL ASSETS                    |     62 407 |     64 497 |     62 534 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| EQUITY AND LIABILITIES          |            |            |            |
+---------------------------------+------------+------------+------------+
| Loans and borrowings            |     13 467 |     13 242 |     13 502 |
+---------------------------------+------------+------------+------------+
| Payables                        |     13 796 |     11 179 |     14 105 |
+---------------------------------+------------+------------+------------+
| Government grants               |        126 |        242 |        234 |
+---------------------------------+------------+------------+------------+
| Total current liabilities       |     27 389 |     24 663 |     27 841 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| Loans and borrowings            |      8 745 |     11 480 |      9 540 |
+---------------------------------+------------+------------+------------+
| Payables                        |        190 |        519 |        190 |
+---------------------------------+------------+------------+------------+
| Deferred tax liabilities        |      2 192 |      2 426 |      2 010 |
+---------------------------------+------------+------------+------------+
| Government grants               |      1 140 |      1 306 |      1 087 |
+---------------------------------+------------+------------+------------+
| Total non-current liabilities   |     12 267 |     15 731 |     12 827 |
+---------------------------------+------------+------------+------------+
| TOTAL LIABILITIES               |     39 656 |     40 394 |     40 668 |
+---------------------------------+------------+------------+------------+
|                                 |            |            |            |
+---------------------------------+------------+------------+------------+
| Share capital                   |      7 737 |      7 737 |      7 737 |
+---------------------------------+------------+------------+------------+
| Share premium                   |     14 007 |     14 007 |     14 007 |
+---------------------------------+------------+------------+------------+
| Treasury shares                 |       -390 |       -390 |       -390 |
+---------------------------------+------------+------------+------------+
| Statutory capital reserve       |         51 |         48 |         51 |
+---------------------------------+------------+------------+------------+
| Currency translation reserve    |         30 |         31 |       -214 |
+---------------------------------+------------+------------+------------+
| Retained profit (-loss)         |        636 |      2 004 |         66 |
+---------------------------------+------------+------------+------------+
| Equity attributable to parent   |     22 071 |     23 437 |     21 257 |
+---------------------------------+------------+------------+------------+
| Non-controlling interest        |        680 |        666 |        609 |
+---------------------------------+------------+------------+------------+
| TOTAL EQUITY                    |     22 751 |     24 103 |     21 866 |
+---------------------------------+------------+------------+------------+
| TOTAL EQUITY AND LIABILITIES    |     62 407 |     64 497 |     62 534 |
+---------------------------------+------------+------------+------------+

Consolidated Statement of Profit or Loss And Other Comprehensive Income

+----------------------------------+-------+-------+-------------+-------------+
|Thousand euros                    |3Q 2019|3Q 2018|12m 2018/2019|12m 2017/2018|
+----------------------------------+-------+-------+-------------+-------------+
|Sales                             | 19 329| 19 393|       85,727|       94,871|
+----------------------------------+-------+-------+-------------+-------------+
|Cost of goods sold                |-16 747|-16 437|      -73,830|      -81,694|
+----------------------------------+-------+-------+-------------+-------------+
|Gross profit                      |  2 582|  2 956|       11,897|       13,177|
+----------------------------------+-------+-------+-------------+-------------+
|                                  |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Operating expenses                | -2 598| -2 623|      -10,702|      -10,007|
+----------------------------------+-------+-------+-------------+-------------+
|  Selling and distribution        |       |       |             |             |
|expenses                          | -1 792| -1 843|       -7,499|       -7,125|
+----------------------------------+-------+-------+-------------+-------------+
|  Administrative expenses         |   -806|   -780|       -3,203|       -2,882|
+----------------------------------+-------+-------+-------------+-------------+
|Other income / expense            |    128|    167|           83|         -162|
+----------------------------------+-------+-------+-------------+-------------+
|Fair value adjustment on          |       |       |             |             |
|biological assets                 |    846|     73|       -1,744|         -674|
+----------------------------------+-------+-------+-------------+-------------+
|Operating profit (loss)           |    958|    573|         -466|        2,334|
+----------------------------------+-------+-------+-------------+-------------+
|Financial income/-expenses        |   -203|   -222|         -776|         -936|
+----------------------------------+-------+-------+-------------+-------------+
|Profit (loss) before tax          |    755|    351|       -1,242|        1,398|
+----------------------------------+-------+-------+-------------+-------------+
|Income tax                        |   -185|   -209|         -230|         -399|
+----------------------------------+-------+-------+-------------+-------------+
|Net profit (loss) for the period  |    570|    142|       -1,472|          999|
+----------------------------------+-------+-------+-------------+-------------+
|                                  |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Net profit (loss) attributable to:|       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Owners of the company             |    513|     99|       -1 458|        1,001|
+----------------------------------+-------+-------+-------------+-------------+
|Non-controlling interests         |     57|     43|          -14|           -2|
+----------------------------------+-------+-------+-------------+-------------+
|Total net profit (loss)           |    570|    142|       -1,472|          999|
+----------------------------------+-------+-------+-------------+-------------+
|                                  |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Other comprehensive income (loss) |       |       |             |             |
|that may subsequently be          |       |       |             |             |
|classified to profit or loss:     |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Foreign currency translation      |       |       |             |             |
|differences                       |    315|     24|         -221|         -410|
+----------------------------------+-------+-------+-------------+-------------+
|Total comprehensive income        |       |       |             |             |
|(expense)                         |    885|    166|       -1,693|          589|
+----------------------------------+-------+-------+-------------+-------------+
|                                  |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Total comprehensive income        |       |       |             |             |
|(expense) attributable to:        |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Owners of the Company             |    828|    123|       -1 679|          591|
+----------------------------------+-------+-------+-------------+-------------+
|Non-controlling interests         |     57|     43|          -14|           -2|
+----------------------------------+-------+-------+-------------+-------------+
|Total comprehensive income        |       |       |             |             |
|(expense) for the period          |    885|    166|       -1 693|          589|
+----------------------------------+-------+-------+-------------+-------------+
|                                  |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Profit (loss) per share (EUR)     |   0,02|   0,00|        -0,04|         0,02|
+----------------------------------+-------+-------+-------------+-------------+
|                                  |       |       |             |             |
+----------------------------------+-------+-------+-------------+-------------+
|Diluted profit (loss) per share   |       |       |             |             |
|(EUR)                             |   0,02|   0,00|        -0,04|         0,02|
+----------------------------------+-------+-------+-------------+-------------+

Indrek Kasela

 AS PRFoods

 Member of the Management Board

 Phone: +372 452 1470

 investor@prfoods.ee

 www.prfoods.ee